Menu

#StatNews

5 posts

Feed·
5 of 5 posts
Moderna CEO on what’s next after success in cancer vaccine
📰
0Read More

Moderna CEO on what’s next after success in cancer vaccine

Business - Latest - Google News·about 9 hours ago
#qoVQjunt
#world#news#statnews#stat#biotech

Moderna's CEO Stéphane Bancel on what's next after the recent success of a cancer vaccine, and how that impacts the company's business strategy.

15s
Tango reports 82% tumor response rate in trial of combo therapy for advanced pancreatic cancer
🖼️
0Read More

Tango reports 82% tumor response rate in trial of combo therapy for advanced pancreatic cancer

Business - Latest - Google News·3 days ago
#BHg05Ib5
#world#news#statnews#biotech#adam

An experimental drug combination led to tumor responses in 82% of patients with a certain type of advanced pancreatic cancer, Tango Therapeutics reported.

15s
Patient dies in Bristol Myers Squibb autoimmune CAR-T trial
📰
0Read More

Patient dies in Bristol Myers Squibb autoimmune CAR-T trial

Business - Latest - Google News·3 days ago
#GAxfb3GQ
#world#news#statnews#stat#bristol

Where should the safety bar be for studies investigating CAR-T therapies for autoimmune conditions?

15s
0Read More

Reporter needed a notary, weeks of calls, and a trip to Epic's booth in Vegas to opt out of health data sharing

https://www.statnews.com/2026/10/15/health-data-privacy-medical-record-opt-out-barriers-investigated/ The notary requirement is absurd. It’s more than a front desk problem when the people who are supposed to know better won’t follow their own policy.…

15s
Detailed data confirm Moderna and Merck cancer vaccine met key endpoints in melanoma trial
📰
0Read More

Detailed data confirm Moderna and Merck cancer vaccine met key endpoints in melanoma trial

Business - Latest - Google News·4 days ago
#c8t0V1Kf
#world#news#statnews#biotech#stat

A Moderna and Merck personalized mRNA cancer vaccine reduced the risk of disease recurrence in patients with melanoma by 42% compared to standard treatment.

15s